Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	Oliena Studio Stroke and language recovery: 9000+ videos Español • Italiano • Sardu • English | PDF+

Colorectal Neoplasms

Free Subscription 22.04.2019 1 Am J Surg 3 Anticancer Res 2 Br J Cancer 2 Cancer Lett 2 Cancer Res 3 Clin Cancer Res 8 Eur J Surg Oncol 1 Gastroenterology 1 Gut 2 Int J Cancer 8 Int J Colorectal Dis 1 J Am Coll Surg 1 J Clin Oncol 2 J Natl Cancer Inst 3 Oncol Rep 1 Oncology 1 Oncology (Williston Park) 1 PLoS One

Retrieve available abstracts of this week’s articles: HTML format Text format

Single Articles

Am J Surg

1. KOZMAN MA, Fisher OM, Valle SJ, Alzahrani N, et al
   The volume-time index (VTI) is prognostic in patients with colorectal cancer peritoneal metastases undergoing cytoreductive surgery and intraperitoneal chemotherapy.
   Am J Surg. 2019 Apr 1. pii: S0002-9610(19)30158.
   PubMed     Text format     Abstract available
   
   

   
   Anticancer Res

2. FRANSGAARD T, Hallas J, Thygesen LC, Gogenur I, et al
   Association of Statin Use and Oncological Outcomes After Neoadjuvant Radiotherapy in Patients With Rectal Cancer.
   Anticancer Res. 2019;39:2177-2182.
   PubMed     Text format     Abstract available
   
   
3. PETRUCCIANI N, Carra MC, Martinez-Perez A, Vitali GC, et al
   Comparison of Different Nodal Staging in Patients With Locally Advanced Mid-low Rectal Cancer After Long-term Neoadjuvant Chemoradiation Therapy.
   Anticancer Res. 2019;39:2113-2120.
   PubMed     Text format     Abstract available
   
   
4. SADAHIRO S, Suzuki T, Tanaka A, Okada K, et al
   Induction of CD3+ and FoxP3+ T Cells in Left-sided Colorectal Tumors After UFT/LV Chemotherapy.
   Anticancer Res. 2019;39:1997-2005.
   PubMed     Text format     Abstract available
   
   

   
   Br J Cancer

5. NAGATA H, Ishihara S, Abe H, Ushiku T, et al
   LGR5 expression predicts peritoneal recurrence after curative resection of primary colon cancer.
   Br J Cancer. 2019 Apr 19. pii: 10.1038/s41416-019-0442.
   PubMed     Text format     Abstract available
   
   
6. XU X, Zhu L, Yang Y, Pan Y, et al
   Low tumour PPM1H indicates poor prognosis in colorectal cancer via activation of cancer-associated fibroblasts.
   Br J Cancer. 2019 Apr 16. pii: 10.1038/s41416-019-0450.
   PubMed     Text format     Abstract available
   
   

   
   Cancer Lett

7. ZHANG R, Li X, Wei L, Qin Y, et al
   Lemur tyrosine kinase 2 acts as a positive regulator of NF-kappaB activation and colon cancer cell proliferation.
   Cancer Lett. 2019;454:70-77.
   PubMed     Text format     Abstract available
   
   
8. HE D, Ma Z, Fang C, Ding J, et al
   Pseudophosphatase STYX promotes tumor growth and metastasis by inhibiting FBXW7 function in colorectal cancer.
   Cancer Lett. 2019;454:53-65.
   PubMed     Text format     Abstract available
   
   

   
   Cancer Res

9. LOPES-RAMOS CM, Kuijjer ML, Ogino S, Fuchs CS, et al
   Correction: Gene Regulatory Network Analysis Identifies Sex-Linked Differences in Colon Cancer Drug Metabolism.
   Cancer Res. 2019;79:2084.
   PubMed     Text format    
   
   
10. COMBES E, Andrade AF, Tosi D, Michaud HA, et al
    Inhibition of Ataxia-Telangiectasia Mutated and RAD3-related (ATR) overcomes oxaliplatin resistance and promotes anti-tumor immunity in colorectal cancer.
    Cancer Res. 2019 Apr 15. pii: 0008-5472.CAN-18-2807.
    PubMed     Text format     Abstract available
    
    

    
    Clin Cancer Res

11. FENG Q, Chang W, Mao Y, He G, et al
    Tumor-associated macrophages as prognostic and predictive biomarkers for postoperative adjuvant chemotherapy in patients with stage II colon cancer.
    Clin Cancer Res. 2019 Apr 15. pii: 1078-0432.CCR-18-2076.
    PubMed     Text format     Abstract available
    
    
12. WANG XC, Yue X, Zhang R, Liu TY, et al
    Genome-wide RNAi screening identifies RFC4 as a factor that mediates radioresistance in colorectal cancer by facilitating non-homologous end joining repair.
    Clin Cancer Res. 2019 Apr 12. pii: 1078-0432.CCR-18-3735.
    PubMed     Text format     Abstract available
    
    
13. DIAZ-MAROTO NG, Sanz-Pamplona R, Berdiel-Acer M, Cimas FJ, et al
    Non-canonical TGFb pathway relieves the blockade of IL-1b/TGFb-mediated crosstalk between tumour and stroma: TGFBR1TAK1 inhibition in colorectal cancer.
    Clin Cancer Res. 2019 Apr 12. pii: 1078-0432.CCR-18-3957.
    PubMed     Text format     Abstract available
    
    

    
    Eur J Surg Oncol

14. D'SOUZA N, Lord A, Shaw A, Abulafi M, et al
    Meta-analysis of oncological outcomes of sigmoid cancers: A hidden epidemic of R1 "palliative" resections.
    Eur J Surg Oncol. 2019;45:489-497.
    PubMed     Text format     Abstract available
    
    
15. GRASS JK, Perez DR, Izbicki JR, Reeh M, et al
    Systematic review analysis of robotic and transanal approaches in TME surgery- A systematic review of the current literature in regard to challenges in rectal cancer surgery.
    Eur J Surg Oncol. 2019;45:498-509.
    PubMed     Text format     Abstract available
    
    
16. TUFO A, Dunne DF, Manu N, Lacasia C, et al
    Changing outlook for colorectal liver metastasis resection in the elderly.
    Eur J Surg Oncol. 2019;45:635-643.
    PubMed     Text format     Abstract available
    
    
17. NIEROP PMH, Verseveld M, Galjart B, Rothbarth J, et al
    The liver-first approach for locally advanced rectal cancer and synchronous liver metastases.
    Eur J Surg Oncol. 2019;45:591-596.
    PubMed     Text format     Abstract available
    
    
18. TERSTEEG JJC, van Esch LM, Gobardhan PD, Kint PAM, et al
    Early local recurrence and one-year mortality of rectal cancer after restricting the neoadjuvant therapy regime.
    Eur J Surg Oncol. 2019;45:597-605.
    PubMed     Text format     Abstract available
    
    
19. PENNINGS JP, de Haas RJ, Murshid KJA, de Jong KP, et al
    FDG-avid presacral soft tissue mass in previously treated rectal cancer: Diagnostic outcome and additional value of MRI, including diffusion-weighted imaging.
    Eur J Surg Oncol. 2019;45:606-612.
    PubMed     Text format     Abstract available
    
    
20. HAGEMANS JAW, Alberda WJ, Verstegen M, de Wilt JHW, et al
    Hospital volume and outcome in rectal cancer patients; results of a population-based study in the Netherlands.
    Eur J Surg Oncol. 2019;45:613-619.
    PubMed     Text format     Abstract available
    
    
21. SINGH B, Singh G, Alzahrani N, Arrowaili A, et al
    Long term survival and perioperative propensity score matched outcomes in diaphragmatic interventions in cytoreductive surgery + intra-peritoneal chemotherapy.
    Eur J Surg Oncol. 2019;45:620-624.
    PubMed     Text format     Abstract available
    
    

    
    Gastroenterology

22. FORMIGA MNC, Ashton-Prolla P, Achatz MI
    Early-Onset Colorectal Cancer in Li Fraumeni Syndrome Patients: Is It Really Enough to Justify Early Colon Cancer Screening?
    Gastroenterology. 2019 Apr 11. pii: S0016-5085(19)35693.
    PubMed     Text format    
    
    

    
    Gut

23. KONG F, Li L, Wang G, Deng X, et al
    VDR signaling inhibits cancer-associated-fibroblasts' release of exosomal miR-10a-5p and limits their supportive effects on pancreatic cancer cells.
    Gut. 2018 Apr 25. pii: gutjnl-2018-316627. doi: 10.1136/gutjnl-2018-316627.
    PubMed     Text format    
    
    

    
    Int J Cancer

24. 
    Erratum: Association between metformin use after surgery for colorectal cancer and oncological outcomes: A nationwide register-based study.
    Int J Cancer. 2019;144:E9-E11.
    PubMed     Text format    
    
    
25. CHENG WC, Liao TT, Lin CC, Yuan LE, et al
    RAB27B-activated secretion of stem-like tumor exosomes delivers the biomarker microRNA-146a-5p, which promotes tumorigenesis and associates with an immunosuppressive tumor microenvironment in colorectal cancer.
    Int J Cancer. 2019 Apr 13. doi: 10.1002/ijc.32338.
    PubMed     Text format     Abstract available
    
    

    
    Int J Colorectal Dis

26. TOMASSI MJ, Abbas MA, Klaristenfeld DD
    Expectant management surveillance for patients at risk for invasive squamous cell carcinoma of the anus: a large US healthcare system experience.
    Int J Colorectal Dis. 2019;34:47-54.
    PubMed     Text format     Abstract available
    
    
27. FEINBERG AE, Wallis CJD, Nam RK, Hameed U, et al
    Survival and peri-operative outcomes among patients with rectal cancer: the role of prior radiotherapy due to prostate cancer.
    Int J Colorectal Dis. 2019;34:97-104.
    PubMed     Text format     Abstract available
    
    
28. LEE JH, Jeong JU, Kim SH, Nam TK, et al
    Nadir/pre-chemoradiotherapy ratio of white blood-cell count can predict tumor response and recurrence-free survival in locally advanced rectal cancer: a multi-institutional analysis.
    Int J Colorectal Dis. 2019;34:105-112.
    PubMed     Text format     Abstract available
    
    
29. MA B, Ren Y, Chen Y, Lian B, et al
    Is adjuvant chemotherapy necessary for locally advanced rectal cancer patients with pathological complete response after neoadjuvant chemoradiotherapy and radical surgery? A systematic review and meta-analysis.
    Int J Colorectal Dis. 2019;34:113-121.
    PubMed     Text format     Abstract available
    
    
30. NALLY DM, Ballester AW, Valentelyte G, Kavanagh DO, et al
    The contribution of endoscopy quality measures to the development of interval colorectal cancers in the screening population: a systematic review.
    Int J Colorectal Dis. 2019;34:123-140.
    PubMed     Text format     Abstract available
    
    
31. WILLARD CD, Kjaestad E, Stimec BV, Edwin B, et al
    Preoperative anatomical road mapping reduces variability of operating time, estimated blood loss, and lymph node yield in right colectomy with extended D3 mesenterectomy for cancer.
    Int J Colorectal Dis. 2019;34:151-160.
    PubMed     Text format     Abstract available
    
    
32. CLIMENT M, Ryan EJ, Stakelum A, Khaw YL, et al
    Systemic inflammatory response predicts oncological outcomes in patients undergoing elective surgery for mismatch repair-deficient colorectal cancer.
    Int J Colorectal Dis. 2019 Apr 16. pii: 10.1007/s00384-019-03274.
    PubMed     Text format     Abstract available
    
    
33. SI MB, Yan PJ, Du ZY, Li LY, et al
    Lymph node yield, survival benefit, and safety of high and low ligation of the inferior mesenteric artery in colorectal cancer surgery: a systematic review and meta-analysis.
    Int J Colorectal Dis. 2019 Apr 17. pii: 10.1007/s00384-019-03291.
    PubMed     Text format     Abstract available
    
    

    
    J Am Coll Surg

34. NFONSAM VN, Jecius H, Chen D, Omesiete PN, et al
    Increasing Incidence of Colon Cancer in the Young: Assessing the Tumor Biology.
    J Am Coll Surg. 2019 Apr 14. pii: S1072-7515(19)30257.
    PubMed     Text format     Abstract available
    
    

    
    J Clin Oncol

35. LIEU C, Kennedy EB, Bergsland E, Berlin J, et al
    Duration of Oxaliplatin-Containing Adjuvant Therapy for Stage III Colon Cancer: ASCO Clinical Practice Guideline.
    J Clin Oncol. 2019 Apr 15:JCO1900281. doi: 10.1200/JCO.19.00281.
    PubMed     Text format     Abstract available
    
    

    
    J Natl Cancer Inst

36. TEEPEN JC, Ronckers CM, Kremer LCM
    Colorectal Cancer Screening in Childhood Cancer Survivors.
    J Natl Cancer Inst. 2019 Apr 9. pii: 5454690. doi: 10.1093.
    PubMed     Text format    
    
    
37. GINI A, Meester RGS, Keshavarz H, Oeffinger KC, et al
    Cost-Effectiveness of Colonoscopy-Based Colorectal Cancer Screening in Childhood Cancer Survivors.
    J Natl Cancer Inst. 2019 Apr 13. pii: 5454689. doi: 10.1093.
    PubMed     Text format     Abstract available
    
    

    
    Oncol Rep

38. ZHANG H, Song Y, Yang C, Wu X, et al
    Overexpression of lncRNA TUSC7 reduces cell migration and invasion in colorectal cancer.
    Oncol Rep. 2019 Apr 9. doi: 10.3892/or.2019.7106.
    PubMed     Text format     Abstract available
    
    
39. JIANG J, Li Y, Jiang Z
    Effects of LDOC1 on colorectal cancer cells via downregulation of the Wnt/beta-catenin signaling pathway.
    Oncol Rep. 2019 Apr 17. doi: 10.3892/or.2019.7126.
    PubMed     Text format     Abstract available
    
    
40. XU C, Yu X, Zhu Y, Cai Z, et al
    Overexpression of calpain1 predicts poor outcome in patients with colorectal cancer and promotes tumor cell progression associated with downregulation of FLNA.
    Oncol Rep. 2019 Apr 16. doi: 10.3892/or.2019.7121.
    PubMed     Text format     Abstract available
    
    

    
    Oncology

41. LARSEN FO, Jensen BV, Norgaard HH, Hermann HK, et al
    Intrahepatic Oxaliplatin and Systemic 5-FU +/- Cetuximab in Chemo-Naive Patients with Liver Metastases from Colorectal Cancer.
    Oncology. 2019 Apr 18. pii: 000499314. doi: 10.1159/000499314.
    PubMed     Text format     Abstract available
    
    

    
    Oncology (Williston Park)

42. DRAPER A
    Regorafenib for Metastatic Colorectal Cancer: Common Toxicities and Prevention Strategies.
    Oncology (Williston Park). 2019;33:126-7.
    PubMed     Text format    
    
    

    
    PLoS One

43. NAKAYAMA Y, Iijima T, Wakaume R, Takahashi K, et al
    Microsatellite instability is inversely associated with type 2 diabetes mellitus in colorectal cancer.
    PLoS One. 2019;14:e0215513.
    PubMed     Text format     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Colorectal Neoplasms is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: